A survey of the composition, safety, efficacy and regulation of non-autologous biologic treatments in human musculoskeletal pathologies
Commercialized non-autologous biologics are produced from a variety of human tissues and are intended to treat a wide range of musculoskeletal pathologies. This survey focuses on non-autologous biologic products that are delivered via the topical or percutaneous (i.e., injected) routes. The regulato...
Saved in:
Main Author: | Theodore Sand |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2025-06-01
|
Series: | Exploration of Musculoskeletal Diseases |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100795/100795.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of efficacy and adherence to treatment of patients with osteoarthritis with structure-modifying drug of SYSADOA group
by: I. G. Zolkornyaev
Published: (2024-05-01) -
Use of tanezumab for chronic pain treatment
by: A. E. Karateev, et al.
Published: (2021-05-01) -
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
by: E. L. Nasonov, et al.
Published: (2016-07-01) -
Prevalence of Work-Related Musculoskeletal Disorders among Physical Educators of Hyderabad, Pakistan
by: Hanan Bukhari Syed, et al.
Published: (2024-06-01) -
Improving the efficacy of musculoskeletal pain therapy: the role of B-group vitamins combination (descriptive review)
by: A. E. Karateev
Published: (2025-06-01)